Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study.

Conde E, Hernandez S, Martinez R, Angulo B, De Castro J, Collazo-Lorduy A, Jimenez B, Muriel A, Mate JL, Moran T, Aranda I, Massuti B, Rojo F, Domine M, Sansano I, Garcia F, Felip E, Mancheño N, Juan O, Sanz J, Gonzalez-Larriba JL, Atienza-Cuevas L, Arriola-Arellano E, Abdulkader I, Garcia-Gonzalez J, Camacho C, Rodriguez-Abreu D, Teixido C, Reguart N, Gonzalez-Piñeiro A, Lazaro-Quintela M, Lozano MD, Gurpide A, Gomez-Roman J, Lopez-Brea M, Pijuan L, Salido M, Arriola E, Company A, Insa A, Esteban-Rodriguez I, Saiz M, Azkona E, Alvarez R, Artal A, Plaza ML, Aguiar D, Enguita AB, Benito A, Paz-Ares L, Garrido P, Lopez-Rios F.

J Thorac Oncol. 2019 Jul 23. pii: S1556-0864(19)30562-3. doi: 10.1016/j.jtho.2019.07.005. [Epub ahead of print]

2.

Local Investment in Training Drives Electronic Health Record User Satisfaction.

Longhurst CA, Davis T, Maneker A, Eschenroeder HC Jr, Dunscombe R, Reynolds G, Clay B, Moran T, Graham DB, Dean SM, Adler-Milstein J; Arch Collaborative.

Appl Clin Inform. 2019 Mar;10(2):331-335. doi: 10.1055/s-0039-1688753. Epub 2019 May 15. No abstract available.

3.

Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.

Morán T, Felip E, Bosch-Barrera J, de Aguirre I, Ramirez JL, Mesia C, Carcereny E, Roa D, Sais E, García Y, Blanco R, Sanchez S, Villacorta CR, Queralt C, Velarde JM, Rosell R.

Oncotarget. 2019 Apr 2;10(26):2576. doi: 10.18632/oncotarget.26855. eCollection 2019 Apr 2.

4.

The effect of co-occurrence and relational information on speeded evaluation.

Moran T, Bar-Anan Y.

Cogn Emot. 2019 Apr 15:1-12. doi: 10.1080/02699931.2019.1604321. [Epub ahead of print]

PMID:
30987542
5.

Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.

Schwartz C, Moran T, Saunders SP, Kaszlikowska A, Floudas A, Bom J, Nunez G, Iwakura Y, O'Neill L, Irvine AD, McKenzie ANJ, Ogg G, Walsh PT, Demengeot J, Fallon PG.

Allergy. 2019 Apr 2. doi: 10.1111/all.13801. [Epub ahead of print]

PMID:
30937919
6.

Vaccine hesitancy in Indonesia.

Pronyk P, Sugihantono A, Sitohang V, Moran T, Kadandale S, Muller S, Whetham C, Kezaala R.

Lancet Planet Health. 2019 Mar;3(3):e114-e115. doi: 10.1016/S2542-5196(18)30287-0. No abstract available. Erratum in: Lancet Planet Health. 2019 Jul;3(7):e294.

7.

A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.

Moran T, Quiroga V, Cirauqui B, Vila L, Gil-Moreno M, Carcereny E, Margeli M, Muñoz-Marmol A, Mate JL, Velarde JM, Molina MA, Rosell R.

Oncol Res Treat. 2019;42(3):107-114. doi: 10.1159/000495666. Epub 2019 Feb 23.

PMID:
30799393
8.

Integrated respiratory and palliative care leads to high levels of satisfaction: a survey of patients and carers.

Smallwood N, Moran T, Thompson M, Eastman P, Le B, Philip J.

BMC Palliat Care. 2019 Jan 19;18(1):7. doi: 10.1186/s12904-019-0390-0.

9.

Predictors of an Initial Academic Position in Emergency Medicine.

Singhapricha T, Minkhorst O, Moran T, Swanson J, Shayne P.

West J Emerg Med. 2019 Jan;20(1):127-131. doi: 10.5811/westjem.2018.10.39096. Epub 2018 Nov 13.

10.

Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.

Karachaliou N, Bracht JWP, Fernandez Bruno M, Drozdowskyj A, Gimenez Capitan A, Moran T, Carcereny E, Cobo M, Domine M, Chaib I, Ramirez JL, Camps C, Provencio M, Vergnenegre A, Lopez-Vivanco G, Majem M, Massuti B, Rosell R.

J Thorac Oncol. 2019 Feb;14(2):304-310. doi: 10.1016/j.jtho.2018.10.168. Epub 2018 Nov 22.

PMID:
30472259
11.

Open-label, add-on trial of cetirizine for neuromyelitis optica.

Katz Sand I, Fabian MT, Telford R, Kraus TA, Chehade M, Masilamani M, Moran T, Farrell C, Ebel S, Cook LJ, Rose J, Lublin FD.

Neurol Neuroimmunol Neuroinflamm. 2018 Feb 2;5(2):e441. doi: 10.1212/NXI.0000000000000441. eCollection 2018 Mar.

12.

Is more the better?-cetuximab in non-small cell lung cancer patients.

Moran T.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S195-S197. doi: 10.21037/tlcr.2018.04.14. No abstract available.

13.

How actions change liking: The effect of an action's outcome on the evaluation of the action's object.

Moran T, Bar-Anan Y.

J Exp Psychol Gen. 2018 Nov;147(11):1597-1618. doi: 10.1037/xge0000419.

PMID:
30372112
14.

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Chen HM, van der Touw W, Wang YS, Kang K, Mai S, Zhang J, Alsina-Beauchamp D, Duty JA, Mungamuri SK, Zhang B, Moran T, Flavell R, Aaronson S, Hu HM, Arase H, Ramanathan S, Flores R, Pan PY, Chen SH.

J Clin Invest. 2018 Dec 3;128(12):5647-5662. doi: 10.1172/JCI97570. Epub 2018 Oct 22.

15.

Innate immune activation and depressive and anxious symptoms across the peripartum: An exploratory study.

Osborne LM, Yenokyan G, Fei K, Kraus T, Moran T, Monk C, Sperling R.

Psychoneuroendocrinology. 2019 Jan;99:80-86. doi: 10.1016/j.psyneuen.2018.08.038. Epub 2018 Aug 31.

PMID:
30195110
16.

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.

Duruisseaux M, Martínez-Cardús A, Calleja-Cervantes ME, Moran S, Castro de Moura M, Davalos V, Piñeyro D, Sanchez-Cespedes M, Girard N, Brevet M, Giroux-Leprieur E, Dumenil C, Pradotto M, Bironzo P, Capelletto E, Novello S, Cortot A, Copin MC, Karachaliou N, Gonzalez-Cao M, Peralta S, Montuenga LM, Gil-Bazo I, Baraibar I, Lozano MD, Varela M, Ruffinelli JC, Palmero R, Nadal E, Moran T, Perez L, Ramos I, Xiao Q, Fernandez AF, Fraga MF, Gut M, Gut I, Teixidó C, Vilariño N, Prat A, Reguart N, Benito A, Garrido P, Barragan I, Emile JF, Rosell R, Brambilla E, Esteller M.

Lancet Respir Med. 2018 Oct;6(10):771-781. doi: 10.1016/S2213-2600(18)30284-4. Epub 2018 Aug 9.

17.

Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.

Morán T, Felip E, Bosch-Barrera J, de Aguirre I, Ramirez JL, Mesia C, Carcereny E, Roa D, Sais E, García Y, Blanco R, Sanchez S, Villacorta CR, Queralt C, Velarde JM, Rosell R.

Oncotarget. 2018 Jun 5;9(43):27074-27086. doi: 10.18632/oncotarget.25478. eCollection 2018 Jun 5. Erratum in: Oncotarget. 2019 Apr 2;10(26):2576.

18.

Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 - Syria, 2017-2018.

Mbaeyi C, Wadood ZM, Moran T; MJourn, Ather F, Stehling-Ariza T, Nikulin J, Al Safadi M, Iber J, Zomahoun L, Abourshaid N, Pang H, Collins N, Asghar H, Butt OUI, Burns CC, Ehrhardt D, Sharaf M.

MMWR Morb Mortal Wkly Rep. 2018 Jun 22;67(24):690-694. doi: 10.15585/mmwr.mm6724a5.

20.

Forensic hydro-meteorological analysis of an extreme flash flood: The 2016-05-29 event in Braunsbach, SW Germany.

Bronstert A, Agarwal A, Boessenkool B, Crisologo I, Fischer M, Heistermann M, Köhn-Reich L, López-Tarazón JA, Moran T, Ozturk U, Reinhardt-Imjela C, Wendi D.

Sci Total Environ. 2018 Jul 15;630:977-991. doi: 10.1016/j.scitotenv.2018.02.241. Epub 2018 Mar 7.

PMID:
29554783

Supplemental Content

Loading ...
Support Center